Calcium-41: a technology for monitoring changes in bone mineral
- 7 December 2016
- journal article
- review article
- Published by Springer Science and Business Media LLC in Osteoporosis International
- Vol. 28 (4), 1215-1223
- https://doi.org/10.1007/s00198-016-3849-3
Abstract
The rare, long-lived radiotracer, 41Ca, measured by accelerator mass spectrometry in the urine or serum following incorporation into the bone provides an ultra-sensitive tool to assess changes in bone calcium balance in response to an intervention. Changes in bone balance can be followed for years with one small dose that is both radiologically and biologically non-invasive. Sequential interventions can be compared, with greater precision than they can with biochemical markers of bone turnover and with greater power than with bone densitometry. This method is especially useful to screen interventions over a period of weeks. The development and validation of this tool and its applications are reviewed. Mini abstract: Use of 41Ca measured in the urine or blood by accelerator mass spectrometry to assess bone balance provides a tool to compare the relative efficacy of multiple interventions. This perspective provides insights in the use of this novel method and comparisons with more traditional methods for evaluating the efficacy of interventions.Keywords
This publication has 42 references indexed in Scilit:
- The effect of soy isoflavone on bone mineral density in postmenopausal Taiwanese women with bone loss: a 2-year randomized double-blind placebo-controlled studyOsteoporosis International, 2011
- Development of 41Ca-Based Pharmacokinetic Model for the Study of Bone Remodelling in HumansClinical Pharmacokinetics, 2011
- Tetracycline and Calcium Kinetics Are Comparable for Estimating Bone Resorption in RatsJournal of Nutrition, 2010
- The Soy Isoflavones for Reducing Bone Loss (SIRBL) Study: a 3-y randomized controlled trial in postmenopausal womenThe American Journal of Clinical Nutrition, 2010
- Antiresorptive Effects of Phytoestrogen Supplements Compared with Estradiol or Risedronate in Postmenopausal Women Using 41Ca MethodologyJournal of Clinical Endocrinology & Metabolism, 2009
- The pharmacokinetic behavior of the soy isoflavone metabolite S-(-)equol and its diastereoisomer R-(+)equol in healthy adults determined by using stable-isotope-labeled tracersThe American Journal of Clinical Nutrition, 2009
- Evaluation of 41Calcium as a New Approach to Assess Changes in Bone Metabolism: Effect of a Bisphosphonate Intervention in Postmenopausal Women With Low Bone MassJournal of Bone and Mineral Research, 2007
- 41Ca and Accelerator Mass Spectrometry to Monitor Calcium Metabolism in End Stage Renal Disease PatientsClinical Chemistry, 2005
- The efficacy and tolerability of risedronate on bone mineral density and bone turnover markers in osteoporotic Chinese women: a randomized placebo-controlled studyBone, 2005
- Use of accelerator mass spectrometry for studies in nutritionNutrition Research Reviews, 2001